News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ChanTest Corporation CEO to Speak on New Pre-Clinical Assays for Predicting Cardiotoxicity at Society of Toxicology Annual Meeting


3/4/2010 9:20:38 AM

CLEVELAND--(BUSINESS WIRE)--Arthur “Buzz” Brown, founder, president and CEO of ChanTest and renowned authority on cardiotoxicity in drug development, will speak on the subject at the annual meeting of the Society of Toxicology in Salt Lake City, Utah on March 8. Dr. Brown’s session, which addresses the problem of sudden cardiac death due to non-cardiac drugs (a major safety issue for the pharmaceutical industry and U. S. regulatory bodies), will be held in Room 155 C from 3:30 p.m. – 4:30 p.m. MST in the Salt Palace Convention Center.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES